BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Santos PB, Patel H, Henrique R, Félix A. Can epigenetic and inflammatory biomarkers identify clinically aggressive prostate cancer? World J Clin Oncol 2020; 11(2): 43-52 [PMID: 32133274 DOI: 10.5306/wjco.v11.i2.43]
URL: https://www.wjgnet.com/2218-4333/full/v11/i2/43.htm
Number Citing Articles
1
Teow J. Phua. The Etiology and Pathophysiology Genesis of Benign Prostatic Hyperplasia and Prostate Cancer: A New PerspectiveMedicines 2021; 8(6): 30 doi: 10.3390/medicines8060030
2
Melanie Dzulko, Miriam Pons, Andreas Henke, Günter Schneider, Oliver H. Krämer. The PP2A subunit PR130 is a key regulator of cell development and oncogenic transformationBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(2): 188453 doi: 10.1016/j.bbcan.2020.188453
3
Tanggang Deng, Yugang Xiao, Yi Dai, Lin Xie, Xiong Li. Roles of Key Epigenetic Regulators in the Gene Transcription and Progression of Prostate CancerFrontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.743376
4
Mojtaba Yousefi, Niloofar Eshaghian, Neda Heidarzadeh-Esfahani, Gholamreza Askari, Hamid Rasekhi, Omid Sadeghi. Dietary intake and biomarkers of linoleic acid and risk of prostate cancer in men: A systematic review and dose-response meta-analysis of prospective cohort studiesCritical Reviews in Food Science and Nutrition 2024; 64(24): 8553 doi: 10.1080/10408398.2023.2200840
5
Terrance J. Haanen, Caitlin M. O'Connor, Goutham Narla. Biased holoenzyme assembly of protein phosphatase 2A (PP2A): From cancer to small moleculesJournal of Biological Chemistry 2022; 298(12): 102656 doi: 10.1016/j.jbc.2022.102656
6
Fernando Pereira Beserra, Lucas Fernando Sérgio Gushiken, Maria Fernanda Hussni, Victor Pena Ribeiro, Flávia Bonamin, Christopher John Jackson, Cláudia Helena Pellizzon, Jairo Kenupp Bastos. Artepillin C as an outstanding phenolic compound of Brazilian green propolis for disease treatment: A review on pharmacological aspectsPhytotherapy Research 2021; 35(5): 2274 doi: 10.1002/ptr.6875
7
Marisa Shiina, Yutaka Hashimoto, Priyanka Kulkarni, Pritha Dasgupta, Varahram Shahryari, Soichiro Yamamura, Yuichiro Tanaka, Rajvir Dahiya. Role of miR-182/PDCD4 axis in aggressive behavior of prostate cancer in the African AmericansBMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08723-6
8
Aniekan E. Owen, Ernest C. Agwamba, Mathias E. Gideon, Kelechi Chukwuemeka, Emmanuel U. Ejiofor, Innocent Benjamin, Eze F. Ahukwe, Festus O. Ogungbemiro, Kube T. Maxwell, Amanda-Lee E. Manicum, Hitler Louis. Molecular structure, spectroscopy, molecular docking, and molecular dynamic studies of tetrahydroneoprzewaquinone as potent cervical cancer agentZeitschrift für Physikalische Chemie 2024; 238(2): 363 doi: 10.1515/zpch-2023-0330
9
Radek Kucera, Ladislav Pecen, Ondrej Topolcan, Anshu Raj Dahal, Vincenzo Costigliola, Frank A. Giordano, Olga Golubnitschaja. Prostate cancer management: long-term beliefs, epidemic developments in the early twenty-first century and 3PM dimensional solutionsEPMA Journal 2020; 11(3): 399 doi: 10.1007/s13167-020-00214-1
10
Francisco das Chagas Pereira de Andrade, Anderson Nogueira Mendes. Computational analysis of eugenol inhibitory activity in lipoxygenase and cyclooxygenase pathwaysScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-73203-z